Abstract
We report a case of a 40-year-old male patient who developed a fever one week after recovering from severe COVID-19 illness that had needed treatment with injectable corticosteroids and Tocilizumab.
Cite
CITATION STYLE
APA
KRISHNAMURTHY, P., SHARMA, B., DEEPAK, D., SHUKLA, S., ARYA, V., & CHOWDHARY, A. (2021). Disseminated Histoplasmosis Post-IL6 Inhibitor Use in A COVID-19 Patient. Journal of Microbiology and Infectious Diseases, 170–173. https://doi.org/10.5799/jmid.994001
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free